Literature DB >> 3667035

Trends in dietary fat and cigarette smoking and the decline in coronary heart disease in New Zealand.

R Jackson1, R Beaglehole.   

Abstract

Coronary heart disease (CHD) mortality declined by approximately 23.5% in New Zealand men aged 35-64 years between 1968 and 1980. The contributions of secular trends in dietary fat and tobacco consumption to this decline were examined using data from national consumption statistics and population based studies of risk factor levels. Per capita saturated fat and dietary cholesterol consumption fell by approximately 12% and 10% respectively during this period while polyunsaturated fat consumption increased by 73%. Per capita tobacco consumption fell by approximately 15%. Using equations developed by Keys and Hegsted it was calculated that the mean serum cholesterol level declined by between 6.6 and 10.3 mg/dl (2.9%-4.4%) during this period. The potential impact of these risk factor changes on CHD mortality was estimated using a Framingham multivariate logistic risk function. Between 38% and 51% of the observed decline in CHD mortality in men aged 35-64 years in New Zealand between 1968 and 1980 could be accounted for by the calculated changes in serum cholesterol and tobacco consumption. If serum cholesterol and cigarette smoking were reduced further to meet current recommendations, it is estimated that CHD mortality would decline by a further 26%-30% from the 1980 level.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667035     DOI: 10.1093/ije/16.3.377

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  10 in total

1.  Geographic variation in the onset of decline of male ischemic heart disease mortality in The Netherlands.

Authors:  J P Mackenbach; C W Looman; A E Kunst
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

2.  Commentary: no smoke without fire-the continuing menace of the betel nut in the world's most vulnerable populations.

Authors:  M Justin Zaman
Journal:  Int J Epidemiol       Date:  2014-04-01       Impact factor: 7.196

3.  Sick Populations and Sick Subpopulations: Reducing Disparities in Cardiovascular Disease Between Blacks and Whites in the United States.

Authors:  Yuan Lu; Majid Ezzati; Eric B Rimm; Kaveh Hajifathalian; Peter Ueda; Goodarz Danaei
Journal:  Circulation       Date:  2016-06-20       Impact factor: 29.690

Review 4.  The independent roles of diet and serum lipids in the 20th-century rise and decline of coronary heart disease mortality.

Authors:  R H Rosenman
Journal:  Integr Physiol Behav Sci       Date:  1993 Jan-Mar

5.  Changes in diet and coronary heart disease mortality among social classes in Great Britain.

Authors:  M Morgan; R F Heller; A Swerdlow
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

6.  Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland.

Authors:  E Vartiainen; P Puska; J Pekkanen; J Tuomilehto; P Jousilahti
Journal:  BMJ       Date:  1994-07-02

Review 7.  Contributions of risk factors and medical care to cardiovascular mortality trends.

Authors:  Majid Ezzati; Ziad Obermeyer; Ioanna Tzoulaki; Bongani M Mayosi; Paul Elliott; David A Leon
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

Review 8.  Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.

Authors: 
Journal:  Lancet Diabetes Endocrinol       Date:  2014-05-16       Impact factor: 32.069

9.  Reduced risk of colorectal cancer among recent generations in New Zealand.

Authors:  B Cox; J Little
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

10.  Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants.

Authors:  Yuan Lu; Kaveh Hajifathalian; Majid Ezzati; Mark Woodward; Eric B Rimm; Goodarz Danaei
Journal:  Lancet       Date:  2013-11-22       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.